[Tickers Inside] 7 Solid Gainers Over the Last 5 Sessions

Stocks with 5 days of consecutive price advances. If you cannot see this email properly, please click [here]( [marketinside...] --------------------------------------------------------------- [Investor Alert: EV Initiatives Create Unsustainable Demand For Lithium]( [See how EV demand could create new lithium investment opportunities for you.]([aff_i?offer_...] --------------------------------------------------------------- August 24, 2022 From the desk of the Editor (5 Day Gainers Report) Dear Reader, We just identified 7 Five Day Gainers of all US Exchanges. If you are interested in any of these companies, we encourage you to do your own research and due diligence. Keep reading to see what we just uncovered... --------------------------------------------------------------- [Investors Look to Capitalize on the Budding Green Revolution]( [c581fbef-7c0...](Lithium is the uncontested fuel of the green energy revolution. One little-known small-cap lithium mining company in a renowned South American location has started attracting interest from opportunity-minded investors. [Discover this company's HUGE lithium potential -- before the masses do.](//trailer.web-view.net/Links/0XAAFC8DB31F534EE8DCAADC2B061F5217D2F818321830D6533490EF4CC8E7AEE1EC60EB1E8EF1042D92EF9615B3E2EE3B9052A37B0824CDEB001B444F7491C4D0F598CD369566B7DD.htm [5381a560-c43...]([aff_i?offer_...] --------------------------------------------------------------- [Blueprint Medicines, BPMC]( Recent Analyst Action: Eun Yang, analyst at Jefferies, reiterates coverage on [Blueprint Medicines (BPMC)](in the Healthcare sector with a Buy rating and a price target of $84 (2 days ago). - Recent Price: $74.82 - Average Analyst Price Target: $88.67 (18.51%) - Market Cap: $4.28B [TipRanks.com]( also reports that [Blueprint Medicines](currently has 13 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $88.67. The target pricing ranges from a high forecast of $152.00 down to a low forecast of $41.00. [Blueprint Medicines (BPMC)](’s last closing price was $74.82 which would put the average price target at $88.67. Here are 3rd party ratings for [BPMC](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Hold, Top 28% (70 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [The #1 Stock Under $5]( [cbf0b3ac-70e...](Virginia Stock-Picking Millionaire Says It’s Not About Diversification! Buy one single $3 stock- that trades under a secret name- and it could help make your retirement. [His instructions are here.]( [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- [Evolution Petroleum, EPM]( Recent Analyst Action: Donovan Schafer, analyst at Northland Securities, reiterates coverage on [Evolution Petroleum (EPM)](in the Utilities sector with a Buy rating and a price target of $8.6 (1 month ago). - Recent Price: $7.9 - Average Analyst Price Target: $9.05 (14.56%) - Market Cap: $258.46M [TipRanks.com]( also reports that [Evolution Petroleum](currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $9.05. The target pricing ranges from a high forecast of $9.50 down to a low forecast of $8.60. [Evolution Petroleum (EPM)](’s last closing price was $7.9 which would put the average price target at $9.05. Here are 3rd party ratings for [EPM](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: buy - Zacks.com: Hold, Bottom 48% (131 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- [Allakos, ALLK]( Recent Analyst Action: Patrick Trucchio, analyst at H.C. Wainwright, reiterates coverage on [Allakos (ALLK)](in the Healthcare sector with a Buy rating and a price target of $20 (1 week ago). - Recent Price: $4.22 - Average Analyst Price Target: $11.00 (160.66%) - Market Cap: $228.15M [TipRanks.com]( also reports that [Allakos](currently has 4 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $11.00. The target pricing ranges from a high forecast of $20.00 down to a low forecast of $4.00. [Allakos (ALLK)](’s last closing price was $4.22 which would put the average price target at $11.00. Here are 3rd party ratings for [ALLK](: - TipRanks.com: Hold - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Hold, Top 28% (70 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast: ["Prepare for Five Years of Famine"]( [Screen+Shot+...]( [Click here]( for the name of the one ticker you need to protect yourself.[5381a560-c43...]([aff_i?offer_...] --------------------------------------------------------------- [Bioceres Crop Solutions, BIOX]( Recent Analyst Action: Ben Klieve, analyst at Lake Street, reiterates coverage on [Bioceres Crop Solutions (BIOX)](in the Basic Materials sector with a Buy rating and a price target of $25 (1 month ago). - Recent Price: $14.69 - Average Analyst Price Target: $24.50 (66.78%) - Market Cap: $802.37M [TipRanks.com]( also reports that [Bioceres Crop Solutions](currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $24.50. The target pricing ranges from a high forecast of $25.00 down to a low forecast of $24.00. [Bioceres Crop Solutions (BIOX)](’s last closing price was $14.69 which would put the average price target at $24.50. Here are 3rd party ratings for [BIOX](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: n/a, n/a [Click here for chart >>]( -------------------------------------------------------------------------- [Peabody Energy Comm, BTU]( Recent Analyst Action: Lucas Pipes, analyst at B.Riley Financial, reiterates coverage on [Peabody Energy Comm (BTU)](in the Basic Materials sector with a Buy rating and a price target of $28 (3 weeks ago). - Recent Price: $27.72 - Average Analyst Price Target: $30.67 (10.64%) - Market Cap: $3.94B [TipRanks.com]( also reports that [Peabody Energy Comm](currently has 3 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $30.67. The target pricing ranges from a high forecast of $36.00 down to a low forecast of $28.00. [Peabody Energy Comm (BTU)](’s last closing price was $27.72 which would put the average price target at $30.67. Here are 3rd party ratings for [BTU](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 37% (92 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [Nevada Desert more Valuable than Wall Street or Silicon Valley?]( [170c87b0-23e...](It could be true, according to Nevada Governor Steve Sisolak. The state's desert flats contain more lithium than any other geography in the world. And with electric vehicles driving a global boom in demand for lithium-ion batteries, Nevada should be on every investor's radar. [Find Out How to Take Advantage of Nevada's Lithium Bonanza]( [5381a560-c43...]([aff_i?offer_...] --------------------------------------------------------------- [NuScale Power, SMR]( Recent Analyst Action: Shahriar Pourreza, analyst at Guggenheim, reiterates coverage on [NuScale Power (SMR)](in the Financial sector with a Buy rating and a price target of $18 (6 days ago). - Recent Price: $15.37 - Average Analyst Price Target: $18.00 (17.11%) - Market Cap: $3.25B [TipRanks.com]( also reports that [NuScale Power](currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $18.00. The target pricing ranges from a high forecast of $18.00 down to a low forecast of $18.00. [NuScale Power (SMR)](’s last closing price was $15.37 which would put the average price target at $18.00. Here are 3rd party ratings for [SMR](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Buy, Top 21% (53 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- [MoonLake Immunotherapeutics, MLTX]( Recent Analyst Action: Ram Selvaraju, analyst at H.C. Wainwright, reiterates coverage on [MoonLake Immunotherapeutics (MLTX)](in the Healthcare sector with a Buy rating and a price target of $28 (1 week ago). - Recent Price: $9.58 - Average Analyst Price Target: $28.00 (192.28%) - Market Cap: $474.31M [TipRanks.com]( also reports that [MoonLake Immunotherapeutics](currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $28.00. The target pricing ranges from a high forecast of $28.00 down to a low forecast of $28.00. [MoonLake Immunotherapeutics (MLTX)](’s last closing price was $9.58 which would put the average price target at $28.00. Here are 3rd party ratings for [MLTX](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Hold, Top 28% (70 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [Lithium Triangle a "Treasure Trove" for the Popular Energy Metal]( [4911c126-1cc...](Lithium is the most precious commodity of the green revolution, and experts predict an exploding demand for the energy metal. Surrounded by multi-billion dollar assets, one little-known small-cap company in a renowned location in South America may become a strong link in the lithium supply chain due to a monster acquisition. [Put this company on your radar now.]( [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- And there you have it--7 Five Day Gainers of all US Exchanges. Sincerely, The Editor, MarketInsidersPress.com Market Insider Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. MarketInsidersPress.com part of Sandpiper Marketing Group, LLC 165 Lockerbie Lane | Mooresville NC | 28115 Sandpiper Marketing Group, LLC | 165 Lockerbie Lane | Moorsville | North Carolina | 28115 | United States | 8458030954 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software